PharmaVoice 100: Page 2


  • Header image for Red Jacket Awards
    Image attribution tooltip
    Shaun Lucas/PharmaVoice
    Image attribution tooltip

    The 2022 Red Jacket honorees

    Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

    Sept. 15, 2022
  • Udit Batra header with PV100 logo
    Image attribution tooltip
    Permission granted by Udit Batra
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Udit Batra

    A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”

    By PharmaVoice staff • Sept. 15, 2022
  • A portrait of Jim Lang framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Lang
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Jim Lang

    The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

    By PharmaVoice staff • Sept. 15, 2022
  • Quita Highsmith header
    Image attribution tooltip
    Permission granted by Quita Highsmith
    Image attribution tooltip
    Profile

    Red Jacket: Quita Highsmith

    The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

    By PharmaVoice staff • Sept. 15, 2022
  • A portrait of Jim Anthony framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Anthony
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Jim Anthony

    With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Renata Campos framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Renata Campos
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Renata Campos

    Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lisa Walters-Hoffert framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lisa Walters-Hoffert
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Lisa Walters-Hoffert

    Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Armon Sharei framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Armon Sharei
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Armon Sharei

    The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.

    By Sept. 6, 2022
  • A portrait of Samantha Du framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Du
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Samantha Du

    The CEO of Zai Lab is at the forefront of the movement to boost innovation in China’s biotech sector while delivering needed solutions to patients around the world.

    By Sept. 6, 2022
  • A portrait of Dr. Penelope Manasco framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Penelope Manasco
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Dr. Penelope Manasco

    How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Kunal Ghosh framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kunal Ghosh
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Kunal Ghosh

    The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Adrelia Allen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Adrelia Allen
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Adrelia Allen

    Merck & Co.’s senior director of clinical trial patient diversity is transforming the pharma giant’s approach to inclusion and equality.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dominique Demolle framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dominique Demolle
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Dominique Demolle

    How the CEO of Cognivia is revolutionizing drug development with psychonomics.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Trishna Bharadia framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Trishna Bharadia
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Trishna Bharadia

    As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Jeff Fischer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jeff Fischer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Jeff Fischer

    The co-founder and president led Longhorn Vaccines and Diagnostics to an unprecedented surge in production of its testing tech at the height of COVID-19 and is now pursuing a universal flu vaccine.

    By Karissa Waddick • Sept. 6, 2022
  • A portrait of Henrietta Ukwu framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Henrietta Ukwu
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Henrietta Ukwu

    Novavax’s regulatory head helped the company pull off its first approvals with the FDA and the EMA — but her accomplishments in pharma run deep.

    By Sept. 6, 2022
  • A portrait of Nancy Lurker framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nancy Lurker
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Nancy Lurker

    The CEO of EyePoint Pharmaceuticals is positioning the company to fundamentally reshape how retinal diseases are treated.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Karin Jooss framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Karin Jooss
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Karin Jooss

    The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.

    By Sept. 6, 2022
  • A portrait of Charlene Stern framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Charlene Stern
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Charlene Stern

    How the chief lawyer of Editas Medicine is using a multi-lens approach to bolster the development of game-changing genomic medicines.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Shanthi Ganeshan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Shanthi Ganeshan
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Shanthi Ganeshan

    The longtime regulatory pro has used innovative strategies to deliver emerging oncology therapies to patients from her position as head of regulatory affairs at Stemline.

    By Sept. 6, 2022
  • A portrait of Dr. Mary-Ann Etiebet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mary-Ann Etiebet
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Dr. Mary-Ann Etiebet

    Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Johnna Wesley framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Johnna Wesley
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Johnna Wesley

    The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Ben Yerxa framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ben Yerxa
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Ben Yerxa

    The CEO in retinal diseases sees opportunities for drug development success by merging the work of a gene therapy startup with venture philanthropy.

    By Sept. 6, 2022
  • A portrait of Samantha Singer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Singer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Samantha Singer

    Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Faraz Ali framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by NASDAQ
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Faraz Ali

    The CEO is leading Tenaya Therapeutics forward in ways that combine people-focused leadership, a strong dedication to patients and bold ideas for the future.

    By Alexandra Pecci • Sept. 6, 2022